[{"address1": "One World Trade Center", "address2": "Suite 8500", "city": "New York", "state": "NY", "zip": "10007", "country": "United States", "phone": "212-220-6633", "website": "https://www.mindmed.co", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company's lead product candidates include MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM-402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase I clinical trials for the treatment of core symptoms of autism spectrum disorder. Mind Medicine (MindMed) Inc. is headquartered in New York, New York.", "fullTimeEmployees": 57, "companyOfficers": [{"maxAge": 1, "name": "Mr. Robert  Barrow", "age": 34, "title": "CEO & Director", "yearBorn": 1989, "fiscalYear": 2023, "totalPay": 931133, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Daniel Rollings Karlin M.A., M.D.", "age": 43, "title": "Chief Medical Officer", "yearBorn": 1980, "fiscalYear": 2023, "totalPay": 658522, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Miriam Halperin Wernli B.A., M.A., M.B.A., MBA, Ph.D.", "age": 70, "title": "Executive President", "yearBorn": 1953, "fiscalYear": 2023, "totalPay": 552464, "exercisedValue": 0, "unexercisedValue": 1030416}, {"maxAge": 1, "name": "Dr. Scott M. Freeman M.D.", "age": 66, "title": "Co-Founder & Clinical Advisor", "yearBorn": 1957, "fiscalYear": 2023, "totalPay": 315366, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Leonard  Latchman", "title": "Co-founder", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Carrie F. Liao CPA, CGMA", "age": 57, "title": "VP & Chief Accounting Officer", "yearBorn": 1966, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mark R. Sullivan J.D.", "age": 52, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1971, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Francois P. Lilienthal M.B.A., M.D.", "title": "Chief Commercial Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 5, "compensationRisk": 10, "shareHolderRightsRisk": 3, "overallRisk": 8, "governanceEpochDate": 1719792000, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 7.1, "open": 7.11, "dayLow": 6.91, "dayHigh": 7.1493, "regularMarketPreviousClose": 7.1, "regularMarketOpen": 7.11, "regularMarketDayLow": 6.91, "regularMarketDayHigh": 7.1493, "beta": 2.391, "forwardPE": -4.701987, "volume": 854418, "regularMarketVolume": 854418, "averageVolume": 1418472, "averageVolume10days": 1913940, "averageDailyVolume10Day": 1913940, "bid": 7.08, "ask": 7.11, "bidSize": 400, "askSize": 400, "marketCap": 510294048, "fiftyTwoWeekLow": 2.41, "fiftyTwoWeekHigh": 12.22, "fiftyDayAverage": 8.1145, "twoHundredDayAverage": 5.79265, "currency": "USD", "enterpriseValue": 272152192, "floatShares": 58729112, "sharesOutstanding": 71872400, "sharesShort": 6744850, "sharesShortPriorMonth": 6133922, "sharesShortPreviousMonthDate": 1715731200, "dateShortInterest": 1718323200, "sharesPercentSharesOut": 0.0938, "heldPercentInsiders": 0.011879999, "heldPercentInstitutions": 0.4894, "shortRatio": 4.88, "shortPercentOfFloat": 0.0939, "impliedSharesOutstanding": 71872400, "bookValue": 2.755, "priceToBook": 2.5771325, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -125317000, "trailingEps": -2.93, "forwardEps": -1.51, "lastSplitFactor": "1:15", "lastSplitDate": 1661731200, "52WeekChange": 0.6824645, "SandP52WeekChange": 0.24919295, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "MNMD", "underlyingSymbol": "MNMD", "shortName": "Mind Medicine (MindMed) Inc.", "longName": "Mind Medicine (MindMed) Inc.", "firstTradeDateEpochUtc": 1479220200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "82effaa6-cea3-362e-b9a1-33a692529ba0", "messageBoardId": "finmb_631045282", "gmtOffSetMilliseconds": -14400000, "currentPrice": 7.1, "targetHighPrice": 36.0, "targetLowPrice": 16.0, "targetMeanPrice": 24.25, "targetMedianPrice": 21.0, "recommendationMean": 1.7, "recommendationKey": "buy", "numberOfAnalystOpinions": 8, "totalCash": 252332000, "totalCashPerShare": 3.511, "totalDebt": 14190000, "quickRatio": 3.866, "currentRatio": 3.914, "debtToEquity": 7.238, "returnOnAssets": -0.27609, "returnOnEquity": -0.76787, "freeCashflow": 493250, "operatingCashflow": -67632000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-07-11"}]